Sumichika, Y.; Yoshida, S.; Suzuki, E.; Saito, K.; Matsumoto, H.; Temmoku, J.; Fujita, Y.; Matsuoka, N.; Asano, T.; Sato, S.;
et al. Real-World Effectiveness of Belimumab in Patients with Active Lupus. J. Clin. Med. 2023, 12, 7627.
https://doi.org/10.3390/jcm12247627
AMA Style
Sumichika Y, Yoshida S, Suzuki E, Saito K, Matsumoto H, Temmoku J, Fujita Y, Matsuoka N, Asano T, Sato S,
et al. Real-World Effectiveness of Belimumab in Patients with Active Lupus. Journal of Clinical Medicine. 2023; 12(24):7627.
https://doi.org/10.3390/jcm12247627
Chicago/Turabian Style
Sumichika, Yuya, Shuhei Yoshida, Eiji Suzuki, Kenji Saito, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato,
and et al. 2023. "Real-World Effectiveness of Belimumab in Patients with Active Lupus" Journal of Clinical Medicine 12, no. 24: 7627.
https://doi.org/10.3390/jcm12247627
APA Style
Sumichika, Y., Yoshida, S., Suzuki, E., Saito, K., Matsumoto, H., Temmoku, J., Fujita, Y., Matsuoka, N., Asano, T., Sato, S., & Migita, K.
(2023). Real-World Effectiveness of Belimumab in Patients with Active Lupus. Journal of Clinical Medicine, 12(24), 7627.
https://doi.org/10.3390/jcm12247627